6-Chloro-n,n-dimethyl-5-nitropyrimidin-4-amine, 95+%, 250mg

3,5-Dimethyl-4-[(2-nitrophenyl)thio]-1H-pyrazole, 95.0%, 500mg

3-(Azepan-1-ylmethyl)-6-bromo-1H-indole, 95.0%, 250mg

2-Methoxy-4-(methylsulfonyl)aniline, 95.0%, 10g

2-Ethylhexyl Acrylate Monomer (stabilized with MEHQ)>99.0%(GC)500mL

(S)-1-(4-(Dimethylamino)-3-methylbenzyl)-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid compound with 2,2,2-trifluoroacetic acid (1:2), 98%, 1mg

6-bromopyrazolo[1,5-a]pyridin-3-amine, 97.00, 5g

3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHYL)ANILINE, 95.0%, 100mg

3-Chloro-4-(trifluoromethoxy)benzyl alcohol, 95.0%, 10g

1-[3-(1-aminoethyl)phenyl]imidazolidin-2-one, 95.0%, 250mg

2-Bromo-6-(1H-imidazol-1-yl)pyridine, 95+%, 1g

2-(2-prop-2-ynoxyethoxy)ethyl methanesulfonate, 95, 10g

6-METHOXYTETRALIN-5-CARBOXYLIC ACID, 95%, 1g